Aridis Pharmaceuticals
Chemicals & Related Products · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
983 University Ave Bldg B, Los Gatos, Ca...Phone Number
(408) 385-1742Website
www.aridispharma.comRevenue
$22.4 MillionStock Symbol
ARDSIndustry
About Aridis Pharmaceuticals
Aridis Pharmaceuticals is a late-stage clinical development company focused on creating innovative therapies for life-threatening viral and bacterial respiratory infections. Their product pipeline includes novel monoclonal antibodies and small molecule anti-infectives designed to combat antibiotic-resistant infections and viral pandemics. The company targets clients in need of advanced treatments for conditions such as hospital-acquired infections, cystic fibrosis, and COVID-19. With a proprietary technology platform, Aridis aims to discover and develop rare, potent human monoclonal antibodies to address significant public health threats.Explore more
Aridis Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aridis Pharmaceuticals
Compare insights from companies similar to Aridis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aridis Pharmaceuticals Tech Stack
A closer look at the technologies used by Aridis Pharmaceuticals
See more technologies
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aridis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Aridis Pharmaceuticals is a late-stage clinical development company focused on creating innovative therapies for life-threatening viral and bacterial respiratory infections. Their product pipeline includes novel monoclonal antibodies and small molecule anti-infectives designed to combat antibiotic-resistant infections and viral pandemics. The compa... Read More
